Hansa Biopharma AB (publ) announced that the Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting (AGM) on June 30, 2022 and has the following composition: Natalie Berner representing Redmile Group; Jannis Kitsakis representing AP4; Arne Myhrman representing Thomas Olausson.